Genotype‐phenotype correlation and molecular heterogeneity in pyruvate kinase deficiencyPaola Bianchi, Rachael F. Grace, Madeleine Verhovsek et al.|American Journal of Hematology|2020Cited by 66
Diagnosis and management of pyruvate kinase deficiency: international expert guidelinesHanny Al‐Samkari, Rachael F. Grace, Nadine Shehata et al.|The Lancet Haematology|2024Cited by 15
Early-Onset Osteopenia and Osteoporosis in Patients with Pyruvate Kinase DeficiencyHanny Al‐Samkari, Eduard J. van Beers, Rachael F. Grace et al.|Blood|2020Cited by 5
Early‐onset reduced bone mineral density in patients with pyruvate kinase deficiencyHanny Al‐Samkari, Eduard J. van Beers, Rachael F. Grace et al.|American Journal of Hematology|2023Cited by 4
Bone Mineral Density Remains Stable in Pyruvate Kinase Deficiency Patients Receiving Long-Term Treatment with MitapivatHanny Al‐Samkari, Eduard J. van Beers, Rachael F. Grace et al.|Blood|2021Cited by 3